Form 4: IonQ Director Exercises Options and Sells Shares Under Pre-Arranged Trading Plan

IonQ, Inc. Director Wendy Thomas executed a pre-planned transaction, exercising stock options and subsequently selling a portion of her common stock holdings.

Summary

• IonQ, Inc. Director Wendy Thomas reported transactions involving the company's common stock on June 12, 2025.
• Ms. Thomas acquired 5,000 shares of common stock by exercising stock options at a price of $4.62 per share.
• Concurrently, she disposed of 16,696 shares of common stock through sales at a weighted average price of $39.4284 per share.
• The sales occurred in multiple transactions with prices ranging from $38.67 to $40.46.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Ms. Thomas on March 13, 2025.
• Following these transactions, Ms. Thomas directly beneficially owns 61,145 shares of common stock and 54,350 stock options.
• The stock option exercised was part of an original grant for 59,350 shares, vesting in three equal annual installments commencing December 8, 2023.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While a director selling shares can sometimes be viewed negatively, the transactions were pre-planned under a 10b5-1 plan, which mitigates concerns about opportunistic selling based on undisclosed information. The director realized significant profit from the transactions.

Positives

• The exercise of stock options at a low price of $4.62 indicates a significant unrealized gain for the director.
• The subsequent sale of shares at a high weighted average price of $39.4284 demonstrates the director's ability to realize substantial profits from her equity holdings.

Negatives

• The director sold more shares (16,696) than she acquired through option exercise (5,000), resulting in a net reduction of her direct common stock holdings.
• While conducted under a 10b5-1 plan, insider selling, particularly a net reduction in holdings, can sometimes be perceived negatively by investors as it may suggest a lack of further upside potential or a desire for liquidity.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. IonQ operates in the quantum computing industry.

Stakeholder Impact

• Shareholders may interpret the director's net sale of shares as a signal, though the pre-planned nature of the transaction under a 10b5-1 plan suggests it is for personal financial management rather than a reflection of company-specific concerns.

Next Steps

• The remaining 54,350 stock options held by the reporting person will continue to vest in equal annual installments, subject to continued service, with the original grant commencing December 8, 2023.

Key Dates

Keywords

IonQ, IONQ, Form 4, Insider Trading, Stock Options, Share Sale, Director, Beneficial Ownership, 10b5-1 Plan